Philip Low, founder of NeuroVigil, Inc. spoke at last year’s TEDMED about the impressive EEG analysis technology he has invented. According to Low, NeuroVigil’s algorithms are able to identify electrical events within the brain that are either efferent or afferent signals for specific things happening within the body. For example, one can detect electric potentials of a subject blinking or electrical changes behind a particular neurologic disease doing its thing within the brain. The company is currently working on implementing this technology to more readily identify whether psychiatric drugs are being effective during clinical trials.
Here’s the full video from Philip Low’s talk at TEDMED 2009:
We got a chance to interview Philip after his talk and he took the opportunity to announce NeuroVigil’s partnership with Roche to use the EEG technology to help with clinical trials: